Key result
Small molecule calcium sensitizers stabilize open cNTnC to facilitate cardiac troponin I binding.
Why the study?
Structural studies had located small molecule binding sites on cNTnC but had not shown their influence on the energetics of hydrophobic domain opening.
Umbrella sampling simulations reveal that small molecule calcium sensitivity modulators alter the free energy of cardiac troponin C hydrophobic patch opening, providing mechanistic insights into potential treatments for heritable cardiomyopathies.
May guide troponin-targeted drug design in cardiomyopathy; hypothesis-generating from simulations alone.
Cardiac troponin C (cTnC) binds intracellular calcium and subsequently cardiac troponin I (cTnI), initiating cardiac muscle contraction. Due to its role in contraction, cTnC has been a therapeutic target in the search for small molecules to treat conditions that interfere with normal muscle contraction like the heritable cardiomyopathies. Structural studies have shown the binding location of small molecules such as bepridil, dfbp-o, 3-methyldiphenylamine (DPA), and W7 to be a hydrophobic pocket in the regulatory domain of cTnC (cNTnC) but have not shown the influence of these small molecules on the energetics of opening this domain. Here we describe an application of an umbrella sampling method used to elucidate the impact these calcium sensitivity modulators have on the free energy of cNTnC hydrophobic patch opening. We found that all these molecules lowered the free energy of opening in the absence of the cTnI, with bepridil facilitating the least endergonic transformation. In the presence of cTnI, however, we saw a stabilization of the open configuration due to DPA and dfbp-o binding, and a destabilization of the open configuration imparted by bepridil and W7. Predicted poor binding molecule NSC34337 left the hydrophobic patch in under 3 ns in conventional MD simulations suggesting that only hydrophobic patch binders stabilized the open conformation. In conclusion, this study presents a novel approach to study the impact of small molecules on hydrophobic patch opening through umbrella sampling, and it proposes mechanisms for calcium sensitivity modulation.
No takes yet. Share an insight, caveat, or question.
Bowman et al. (2019) studied Cardiomyopathy. Small molecule calcium sensitivity modulators (bepridil, dfbp-o, DPA, W7) vs. Small molecule-free cNTnC was evaluated on Relative free energy of cNTnC hydrophobic patch opening. In umbrella sampling simulations, small molecule calcium sensitizers lowered the free energy of opening of the cNTnC hydrophobic patch, stabilizing the open configuration to facilitate cTnI binding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: